DOJ Declares FDA Unable to Regulate Execution Drugs

Ruling could put an end to the legal fight between Texas and the FDA

The U.S. Department of Justice may have put an end to a four-year battle between Texas and the U.S. Food and Drug Administration. On Tuesday evening, May 14, the DOJ posted a 26-page memo declaring the FDA unable to regulate drugs used to carry out executions because its job is to ensure drugs are "safe and effective" for their intended use. Referencing a 2000 Supreme Court ruling that the FDA lacked authority to regulate tobacco – because there's no safe way to use tobacco – lethal injection drugs, the DOJ memo argues, aren't intended to be "safe."

Lethal injection drugs have been increasingly difficult to obtain in the U.S. as more and more pharmaceutical companies forbid their drugs to be used in executions. The fight between the Texas Department of Criminal Justice and the FDA dates back to 2015, when the administration intercepted a shipment of the lethal injection drug known as sodium thiopental from India; a 2012 federal court ruling (unrelated to Texas' case) had ordered the FDA to ban the import of the drug, and many countries continue to ban its export. In April 2017, the administration issued its final decision to refuse entry to the 2015 shipment. The TDCJ fought the ruling and a decision has been pending ever since. However, it remains unclear how the DOJ's Tuesday ruling will affect Texas, which has been using pentobarbital for executions since 2012.

A note to readers: Bold and uncensored, The Austin Chronicle has been Austin’s independent news source for almost 40 years, expressing the community’s political and environmental concerns and supporting its active cultural scene. Now more than ever, we need your support to continue supplying Austin with independent, free press. If real news is important to you, please consider making a donation of $5, $10 or whatever you can afford, to help keep our journalism on stands.

Support the Chronicle  

More Death Watch
Death Watch: Defense to D.A. – A Conflict of Interest?
Death Watch: Defense to D.A. – A Conflict of Interest?
John Hummel's attorney calls original trial lawyer's presence in D.A.s office "an irresolvable conflict of interest," seeks to stop execution on that ground

Brant Bingamon, March 13, 2020

Death Watch: Mitigation Appeal Denied, Abel Ochoa Set to Die
Death Watch: Mitigation Appeal Denied, Abel Ochoa Set to Die
He’ll become the first person executed in Texas in 2020

Brant Bingamon, Jan. 31, 2020

More by Sarah Marloff
Travis D.A. Announces New Policies to Support Rape, Abuse Survivors
Travis D.A. Announces New Policies to Support Rape, Abuse Survivors
D.A.’s Office commits to culture change to aid access to justice

Feb. 26, 2021

Assault Plaintiffs Get Court Date
Assault Plaintiffs Get Court Date
Fifth Circuit set to hear oral arguments in late March

Feb. 19, 2021


Department of Justice, FDA, Food and Drug Administration, Death Watch, Texas Department of Criminal Justice, sodium thiopental, pentobarbital

One click gets you all the newsletters listed below

Breaking news, arts coverage, and daily events

Can't keep up with happenings around town? We can help.

Austin's queerest news and events

New recipes and food news delivered Mondays

All questions answered (satisfaction not guaranteed)

Information is power. Support the free press, so we can support Austin.   Support the Chronicle